CVS Plans Merger with Drug-Plan Manager
One of the nation's biggest drugstore chains is merging with a big manager of drug-benefit plans. If completed, the combination of CVS and Caremark would control more than a billion prescriptions every year.
Copyright © 2006 National Public Radio®. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.
RENEE MONTAGNE, host:
And one of the nation's biggest drugstore chains is merging with a big manager of drug benefit plans. The combined company would control more than a billion prescriptions every year. NPR's Scott Horsley reports.
SCOTT HORSLEY: CVS operates more than 6,000 drugstores around the country. Caremark RX sells drugs by mail and manages drug benefits for health plans. CVS Chairman Tom Ryan says putting the two together will save money for employers and others who sponsor health plans, while allowing consumers to get their drugs where and how they want.
Mr. TOM RYAN (Chairman, CVS): Combining Caremark's expertise in serving employers, with our expertise in serving consumers, will help employers and health plans better manage costs and the complexities of the U.S. healthcare system.
HORSLEY: The companies expect to save hundreds of millions of dollars for shareholders by streamlining operations and buying in bulk. But at least one observer is skeptical that consumers will share in those savings. Harvard Health Economist Meredith Rosenthal says Caremark already negotiates discounts on brand name drugs and merging with CVS may not give the firm any more leverage.
At the same time she warns Caremark may put less pressure on CVS to pass along the discounts it negotiates on generic drugs.
Ms. MEREDITH ROSENTHAL (Health Economist, Harvard): Consumers might be hurt because it's all one company.
HORSLEY: The combined company will still have to compete with Wal-Mart's newly discounted generics. Both CVS and Caremark say that played no role in their merger.
Scott Horsley, NPR News.
Copyright © 2006 National Public Radio®. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to National Public Radio. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.
NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.







Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.